Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC5 | O15392 | 1/20 | 0.43 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 5/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 3/20 | 0.39 |
| ▸ | SI | P14410 | 3/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 3/20 | 0.39 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22183174 | 0.91 | HSD17B1 (0.45) | BIRC5HSD17B1HSD17B2RAB9ANPC1 | |
| SCHEMBL22362215 | 0.83 | PSMB5 (0.49) | HSD17B1HSD17B2RAB9ANPC1KDM4E | |
| SCHEMBL17426510 | 0.82 | HSD17B1 (0.43) | HSD17B1HSD17B2KDM1APSMB5 | |
| SCHEMBL2482706 | 0.81 | CYP3A4 (0.54) | BIRC5HSD17B1HSD17B2RAB9ANPC1 | |
| SCHEMBL17209586 | 0.81 | ALDH1A1 (0.52) | BIRC5RAB9ANPC1GAAKDM4E | |
| SCHEMBL16743582 | 0.81 | CCR1 (0.48) | HSD17B1HSD17B2SMN1; SMN2MAPTMEN1 | |
| SCHEMBL17426506 | 0.79 | IKBKB (0.41) | BIRC5RAB9ANPC1GAAKDM4E | |
| SCHEMBL22660886 | 0.78 | HSD17B1 (0.54) | BIRC5HSD17B1HSD17B2RAB9ANPC1 | |
| SCHEMBL12622323 | 0.76 | CCR1 (0.39) | HSD17B1HSD17B2RAB9ANPC1KDM4E | |
| SCHEMBL1925054 | 0.76 | IDO1 (0.53) | BIRC5HSD17B1HSD17B2RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180097189-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-04-05 | — | — | US | disclosed |
| US-9865826-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-01-09 | — | — | US | disclosed |
| US-20160013431-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-01-14 | — | — | US | disclosed |
| US-20160013431-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180097189-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LEF1, CRY1, CYP1A1 | BIRC5 3379/4885HSD17B1 1113/4885HSD17B2 1451/4885 |
| US-20160013431-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LEF1, CRY1, CYP1A1 | BIRC5 3379/4885HSD17B1 1113/4885HSD17B2 1451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.